15769918

Source:http://linkedlifedata.com/resource/pubmed/id/15769918

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0010583, umls-concept:C0024141, umls-concept:C0025815, umls-concept:C0027854, umls-concept:C0205082, umls-concept:C0936233
pubmed:issue	4
pubmed:dateCreated	2005-3-16
pubmed:abstractText	Severe neurological involvement in systemic lupus erythematosus (NPSLE) is one of the most dreadful complications of the disease.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/15769918-10357127, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769918-10483012, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769918-10568892, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769918-10908541, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769918-11547745, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769918-12048286, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769918-12734893, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769918-1356175, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769918-14596432, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769918-14714905, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769918-14714912, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769918-14714914, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769918-1578449, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769918-1599520, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769918-1808642, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769918-2327432, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769918-2350572, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769918-2624244, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769918-2746567, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769918-3259286, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769918-7138600, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769918-7716711, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769918-7825616, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769918-8493429, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769918-8809444, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769918-8856607, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769918-8869901, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769918-9517765, http://linkedlifedata.com/resource/pubmed/commentcorrection/15769918-9814685
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0372355
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Methylprednisolone
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	0003-4967
pubmed:author	pubmed-author:Alocer-VarelaJJ, pubmed-author:Ariza-AndracaRR, pubmed-author:Barile-FabrisLL, pubmed-author:ClarkPP, pubmed-author:Fraga-MouretAA, pubmed-author:Fuentes de la MataJJ, pubmed-author:JaraL JLJ, pubmed-author:Miranda-LimónJ MJM, pubmed-author:Olguín-OrtegaLL, pubmed-author:VargasFF
pubmed:issnType	Print
pubmed:volume	64
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	620-5
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:15769918-Acute Disease, pubmed-meshheading:15769918-Adolescent, pubmed-meshheading:15769918-Adult, pubmed-meshheading:15769918-Antirheumatic Agents, pubmed-meshheading:15769918-Cyclophosphamide, pubmed-meshheading:15769918-Drug Administration Schedule, pubmed-meshheading:15769918-Follow-Up Studies, pubmed-meshheading:15769918-Humans, pubmed-meshheading:15769918-Immunosuppressive Agents, pubmed-meshheading:15769918-Lupus Vasculitis, Central Nervous System, pubmed-meshheading:15769918-Methylprednisolone, pubmed-meshheading:15769918-Middle Aged, pubmed-meshheading:15769918-Severity of Illness Index, pubmed-meshheading:15769918-Treatment Outcome
pubmed:year	2005
pubmed:articleTitle	Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus.
pubmed:affiliation	Clinical Epidemiology Research Unit, Hospital Espicialidades, Centro Médico Nacional Instituto Mexicano del Seguro Social, Mexico. lbarile@prodigy.net.mx
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study